by Vora Corporate Finance | Apr 16, 2025 | Insights
There were No main board IPOs in March 2025 against 04 main board IPOs in February 2025. There were 07 SME IPOs in March 2025 as against 06 SME IPOs in February 2025. After heightened activity in 2024, there has been a slowdown in new listings, with no main-board...
by Vora Corporate Finance | Apr 16, 2025 | Insights
The BSE Sensex closed at 77,414.92 gaining by 5.76% and the Nifty 50 closed at 23,519.35 gaining by 6.30% in March 2025, pausing after a six-session rally that erased their 2025 losses, as uncertainty over U.S. reciprocal import tariffs kept investors cautious....
by Vora Corporate Finance | Apr 16, 2025 | Insights
US Tariff War II: The global economy is facing increased uncertainty due to trade tensions, market volatility, and geopolitical risks. The US President is intensifying this instability by initiating trade wars with both allies and adversaries, using tariffs to counter...
by Vora Corporate Finance | Mar 27, 2025 | Insights, Private Equity & IPO
Transaction: Healthcare and life sciences focused PE investor, InvAscent, through India Life Sciences Fund IV (ILSF IV), has invested INR 1,100 million in Geri Care Health Services, India’s first integrated senior citizen-focused healthcare services provider for a...
by Vora Corporate Finance | Mar 27, 2025 | Insights, Merger & Acquisitions
Transaction: Fortis Healthcare Limited is set to acquire the 228-bed Shrimann Superspeciality Hospital in Jalandhar for approximately $53m (INR 462 crores) through a slump sale. The acquisition includes the entire business operations, hospital building, land, and an...
